Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

carilion materials management - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline is indicated as an adjunct in the management of parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy. evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of ‘off’ time, and patient self-rating of treatment success. beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by walking and comparison to previous

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

a-s medication solutions - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline hydrochloride tablets usp are indicated as an adjunct in the management of parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy. evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of 'off' time, and patient self-rating of treatment success. beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by walking

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

a2a integrated pharmaceuticals - selegiline hydrochloride (unii: 6w731x367q) (selegiline - unii:2k1v7gp655) - selegiline hydrochloride tablets, usp are indicated as an adjunct in the management of parkinsonian patients being treated with levodopa/carbidopa who exhibit deterioration in the quality of their response to this therapy. there is no evidence from controlled studies that selegiline has any beneficial effect in the absence of concurrent levodopa therapy. evidence supporting this claim was obtained in randomized controlled clinical investigations that compared the effects of added selegiline or placebo in patients receiving levodopa/carbidopa. selegiline was significantly superior to placebo on all three principal outcome measures employed: change from baseline in daily levodopa/carbidopa dose, the amount of ‘off’ time and patient self-rating of treatment success. beneficial effects were also observed on other measures of treatment success (e.g., measures of reduced end of dose akinesia, decreased tremor and sialorrhea, improved speech and dressing ability and improved overall disability as assessed by walking and comparison to previous state). selegiline hydrochloride is contraindicated in patients with a known hypersensitivity to this drug. selegiline is contraindicated for use with meperidine. this contraindication is often extended to other opioids. (see drug interactions .)

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - chlophedianol hydrochloride (unii: 69qq58998y) (chlophedianol - unii:42c50p12ap) - chlophedianol hydrochloride 24 mg in 5 ml

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - purposes antihistamine nasal decongestant uses temporarily relieves these symptoms due to hay fever (allergic rhinitis) or other upper respiratory allergies: • runny nose • sneezing • itchy, watery eyes • nasal congestion • itching of the nose or throat • sinus congestion and pressure

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots) - purposes expectorant antitussive nasal decongestant - temporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergies - helps loosen phlegm (mucus) - loosens nasal congestion - thin bronchial secretions - drain bronchial tubes - make coughs more productive - clears stuffy nose - clear nasal passageways - shrinks swollen membranes

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - chlophedianol hydrochloride (unii: 69qq58998y) (chlophedianol - unii:42c50p12ap) - chlophedianol hydrochloride 8 mg in 1 ml

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - guaifenesin 388 mg - purpose expectorant nasal decongestant temporarily relieves these symptoms associated with a cough, the common cold, hay fever, or other upper respiratory allergies - helps loosen phlegm (mucus) - loosens nasal congestion - thin bronchial secretions - drain bronchial tubes - make coughs more productive - clears stuffy nose - clear nasal passageways - shrinks swollen membranes

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - chlophedianol hydrochloride (unii: 69qq58998y) (chlophedianol - unii:42c50p12ap), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv), chlorpheniramine maleate (unii: v1q0o9oj9z) (chlorpheniramine - unii:3u6io1965u) - phenylephrine hydrochloride 10 mg - purposes antihistamine nasal decongestant cough suppressant uses temporarily relieves runny nose and alleviates sneezing, itchy, watery eyes due to hay fever or other upper respiratory allergies. temporarily relieves nasal congestion due to the common cold. temporarily controls cough due to minor bronchial irritation occurring with the common cold.

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

gil pharmaceutical corp - guaifenesin (unii: 495w7451vq) (guaifenesin - unii:495w7451vq), dextromethorphan hydrobromide (unii: 9d2rti9kyh) (dextromethorphan - unii:7355x3rots), phenylephrine hydrochloride (unii: 04ja59tnsj) (phenylephrine - unii:1ws297w6mv) - expectorant antitussive nasal decongestant temporarily relieves the symptoms associated with a cough, the common cold, hay fever, or other  upper respiratory allergies. helps loosen phlegm (mucus), loosens nasal congestion, thin bronchial secretions, drain  bronchial tubes, make coughs more productive, clear stuffy nose, clear nasal passageways, and shrinks swollen membranes. • heart disease. • excessive phlegm (mucus). • high blood pressure. • diabetes. • thyroid disease. • difficulty in urination due to enlargement of the prostate gland. • persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema.  • nervousness, dizziness, or sleeplessness occurs.  • symptoms are accompanied by fever, rash,  persistent headache, or excessive phlegm (mucus). • cough and congestion do not  improve within 7 days or tend to recur.  these could be signs of a serious condition.